Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database.

2.50
Hdl Handle:
http://hdl.handle.net/11287/595278
Title:
Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database.
Authors:
Farmer, A; Rodgers, L; Lonergan, M; Shields, Beverley M; Weedon, M; Donnelly, L; Holman, R R; Pearson, E R; Hattersley, Andrew T.
Abstract:
The impact of taking oral glucose-lowering medicines intermittently, rather than as recommended, is unclear. We conducted a retrospective cohort study using community-acquired U.K. clinical data (Clinical Practice Research Database [CPRD] and GoDARTS database) to examine the prevalence of nonadherence to treatment for type 2 diabetes and investigate its potential impact on HbA1c reduction stratified by type of glucose-lowering medication.
Citation:
Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database. 2016, 39 (2):258-63 Diabetes Care
Publisher:
American Diabetes Association
Journal:
Diabetes care
Issue Date:
Feb-2016
URI:
http://hdl.handle.net/11287/595278
DOI:
10.2337/dc15-1194
PubMed ID:
26681714
Additional Links:
http://care.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=26681714
Type:
Journal Article
Language:
en
ISSN:
1935-5548
Appears in Collections:
Diabetes/Endocrine Services; Honorary contracts publications; 2016 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorFarmer, Aen
dc.contributor.authorRodgers, Len
dc.contributor.authorLonergan, Men
dc.contributor.authorShields, Beverley Men
dc.contributor.authorWeedon, Men
dc.contributor.authorDonnelly, Len
dc.contributor.authorHolman, R Ren
dc.contributor.authorPearson, E Ren
dc.contributor.authorHattersley, Andrew T.en
dc.date.accessioned2016-01-29T14:59:32Zen
dc.date.available2016-01-29T14:59:32Zen
dc.date.issued2016-02en
dc.identifier.citationAdherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database. 2016, 39 (2):258-63 Diabetes Careen
dc.identifier.issn1935-5548en
dc.identifier.pmid26681714en
dc.identifier.doi10.2337/dc15-1194en
dc.identifier.urihttp://hdl.handle.net/11287/595278en
dc.description.abstractThe impact of taking oral glucose-lowering medicines intermittently, rather than as recommended, is unclear. We conducted a retrospective cohort study using community-acquired U.K. clinical data (Clinical Practice Research Database [CPRD] and GoDARTS database) to examine the prevalence of nonadherence to treatment for type 2 diabetes and investigate its potential impact on HbA1c reduction stratified by type of glucose-lowering medication.en
dc.language.isoenen
dc.publisherAmerican Diabetes Associationen
dc.relation.urlhttp://care.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=26681714en
dc.rightsArchived with thanks to Diabetes careen
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen
dc.titleAdherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database.en
dc.typeJournal Articleen
dc.identifier.journalDiabetes careen
dc.description.fundingWellcome (098395)en
dc.type.versionPublisheden
All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.